Jamie Mullen Email & Phone Number

Haddonfield, Nj, Us

Haddonfield, New Jersey, United States

Greater Philadelphia Area

I provide expertise and guidance in the design, implementation, and interpretation of clinical trials in Neuroscience.

Gaithersburg Md

• Lead deep dive analyses of emerging technologies to advance data science in clinical development• Provide clinical team perspective on valuation of advanced analytics projects

Cambridge, Ma

- Global AstraZeneca medical accountability for AZD3293 (BACE inhibitor for Alzheimer's Disease)- Created and led Clinical Project Team, responsible for budget, management, and integrity of clinical trials.- Responsible for clinical development strategy and maintaining alliance with development partner (Eli Lilly).- Functional manager for Senior Medical Leaders

Cambridge, Massachusetts

• Global medical accountability for entire Neuroscience portfolio, including Anesthesia (Diprivan), Topical Anesthesia (Marcaine/Carbocaine/EMLA), Neurology (Zomig, Vimovo), and Psychiatry (Seroquel and Seroquel XR).• Global late-stage medical accountability for Phase IIB-III beta-secretase inhibitor AZD3293.• Led clinical project teams for all marketed neuroscience brands.

Wilminton, Delaware

• Co-lead three U.S. teams: one for continued lifecycle and regulatory management of Seroquel; one for NDA for novel Phase III antidepressant TC-5214, and one for novel Phase IIB-III intravenous antidepressant AZD6765.• Worked with leaders of the U.S. Marketing Company to prepare for submission and launch of TC-5214 and AZD6765. Responsible for U.S. regulatory interactions. • Responsible for scientific advisory boards and AZ participation in FDA advisory committees for Seroquel, TC-5214, and AZD6765.• Led teams for regulatory responses, REMS, and labeling for all compounds.

Wilmington, Delaware

• Co-lead U.S. team preparing for successful transitions of 1 Phase III-ready, 3 Phase II and 4 Phase I compounds in Psychiatry, Neurology, and Analgesia• Worked with leaders of the Neuroscience Therapeutic Area, Clinical Development, Global Marketing, and U.S. Leadership to develop business cases and risk management programs for compounds in Phase II• Developed advocacy and thought leadership programs in new therapeutic areas

Wilmington, Delaware

• Initiated disease-specific and cross-therapeutic strategic research alliances with key academic institutions in U.S., resulting in 3 large-scale strategic alliances and 10 therapeutic area initiatives• Started a new team and processes to develop and manage research collaborations between AstraZeneca and U.S. academic institutions, across all disease areas• Bridged therapeutic area decision-makers in Sweden and U.K. with operational teams in U.S., resulting in faster and more effective decisions around external research initiatives• Managed U.S. alliance project managers and developed computer-based tools to identify and manage alliance candidates

Wilmington, Delaware

• Led successful development program for Seroquel in generalized anxiety disorder, leading to sNDA submission in 2008.• Led Investigator-Initiated /Local Studies Cross-Functional Team managing over 300 studies worldwide• As Senior Brand Physician for Seroquel, served as medical leader for Global Brand Team and managed brand physicians and research physicians in U.S. and Sweden• Responsible for global nonregistration Phase IV studies• Primary spokesperson for global medical issues for Seroquel and mental health

Wilmington, Delaware

• Led successful U.S. submission for Seroquel in bipolar mania• Medical Leader for Seroquel U.S. Brand Team• Led advisory boards and developed relationships with key thought leaders• Led presubmission meetings with FDA• Managed functional and direct reports, including physicians, research scientists, and support staff

Wilmington, Delaware

• Provided medical leadership for successful launch of Seroquel in U.S.• Medical Leader for Seroquel U.S. Product Team• Responsible for scientific advisory boards• Developed scientific relationships with key U.S. stakeholders, opinion leaders• Started Seroquel Investigator-Initiated Study Program

Pittsburgh, Pennsylvania

• Led clinical, research and training activities for psychiatric service covering three UPMC hospitals• Extended training program to residents and medical students

Pittsburgh, Pennsylvania

• Started new clinical program serving the medical and surgical outpatient services• Started outpatient training program for residents and medical students• Initiated in-clinic services for gastroenterology and dermatology

M.D., Medicine

B.S., Biology, Chemistry